Skip to main content

Table 1 Patient and treatment characteristics

From: An underestimated pitfall of oral candidiasis in head and neck cancer patients undergoing radiotherapy: an observation study

Characteristic n (%)
Sex  
 Male 59 (68.6)
 Female 27 (31.4)
Age  
 Median (IQR) 60 (56–66)
 Range 21–83
Underlying disease  
 DM 5 (5.8)
 HT 23 (26.7)
 HIV 1 (1.2)
Personal history  
 Smoking  
   Never used 21 (24.4)
   Quit 53 (61.6)
  Use currently 12 (14)
 Alcohol  
   Never used 31 (36)
  Quit 43 (50)
   Using currently 12 (14)
 Chewing betel  
   Never 75 (87.2)
  Quit using 5 (5.8)
   Using currently 6 (7)
Oral status  
 Oral hygiene  
   Excellent 3 (3.5)
  Good 68 (79)
   Fair 12 (14)
  Poor 3 (3.5)
 Edentulous gum 16 (18.6)
 Dental wearer 9 (10.5)
Tumor characteristics  
 Tumor site  
   Nasopharynx 37 (43)
  Oropharynx 25 (29.1)
  Oral cavity 24 (27.9)
 T stage  
   T1 13 (15.1)
  T2 18 (21)
   T3 15 (17.4)
  T4 40 (46.5)
 N stage  
   N0 20 (23.3)
  N1 19 (22.1)
   N2 37 (43)
  N3 10 (11.6)
Radiotherapy  
 Postoperative RT 28 (32.6)
 Radical RT 58 (67.4)
RT technique  
 Conventional 37 (43)
  IMRT 49 (57)
RT dose  
 Median (Gy) (IQR) 70 (66–70)
 Range 20–70
Chemotherapy  
 Concurrent chemotherapy 67 (78)
 No chemotherapy 19 (22)
  1. DM, diabetes mellitus; HT, hypertension; HIV, human immunodeficiency virus infection; IMRT, intensity-modulated radiation therapy